alovudine has been researched along with Recrudescence in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jinguji, M; Kajiya, Y; Kitazono, M; Nakajo, M; Tani, A; Yoshiura, T | 1 |
| Morishita, F; Okazawa, H; Orisaka, M; Tsuyoshi, H; Yoshida, Y | 1 |
| Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M | 1 |
| Chen, Z; Cui, Y; Fu, Z; Kong, L; Li, M; Yang, G; Yu, J; Zhao, F | 1 |
| Bencherif, B; DeLoia, JA; Edwards, RP; Elishaev, E; Krivak, TC; Mountz, JM; Richard, SD | 1 |
| Chen, W; Cloughesy, TF; Czernin, J; Dahlbom, M; Ellingson, BM; Geist, C; Phelps, ME; Pope, WB; Satyamurthy, N; Schwarzenberg, J; Silverman, DH | 1 |
| Boucher, KM; Butterfield, RI; Christian, PE; Enslow, MS; Heilbrun, ME; Hoffman, JM; Jensen, RL; Kadrmas, DJ; Morton, KA; Zollinger, LV | 1 |
| Aga, F; Kawai, N; Kudomi, N; Nishiyama, Y; Ono, Y; Yamamoto, Y | 1 |
4 trial(s) available for alovudine and Recrudescence
| Article | Year |
|---|---|
Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; Survival Analysis | 2014 |
Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.
Topics: Aged; Biological Transport; Biomarkers, Tumor; Cell Proliferation; Dideoxynucleosides; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Middle Aged; Ovarian Neoplasms; Pilot Projects; Positron-Emission Tomography; Recurrence; Thymidine Kinase; Tomography, X-Ray Computed | 2011 |
3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Dideoxynucleosides; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Time Factors; Treatment Outcome | 2012 |
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.
Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult | 2012 |
4 other study(ies) available for alovudine and Recrudescence
| Article | Year |
|---|---|
A pilot study for texture analysis of
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2017 |
18F-fluorothymidine PET is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patients.
Topics: Aged; Biomarkers, Tumor; Deoxycytidine; Dideoxynucleosides; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2013 |
¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution | 2014 |
Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Child; Dideoxynucleosides; Female; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Recurrence; Retrospective Studies; Young Adult | 2012 |